Provided by Tiger Trade Technology Pte. Ltd.

Defiance Daily Target 2X Long MRNA ETF

135.00
+0.47000.35%
Volume:53.21K
Turnover:7.30M
Market Cap:56.70M
PE:- -
High:140.08
Open:135.54
Low:134.88
Close:134.53
52wk High:165.00
52wk Low:14.95
Shares:420.00K
Float Shares:420.00K
Volume Ratio:5.45
T/O Rate:12.67%
Dividend:- -
Dividend Rate:- -
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

InspireMD Announces Amendments to Certain Series J and Series K Warrants, Providing Potential Gross Proceeds of Up to $11 Million

GlobeNewswire
·
Sep 21

Ultragenyx price target raised to $35 from $32 at Barclays

TIPRANKS
·
Sep 21

Analysts Offer Insights on Healthcare Companies: Moderna (MRNA) and Amneal Pharmaceuticals (AMRX)

TIPRANKS
·
Sep 21

Amneal Pharmaceuticals announces FDA approval and launch of Lanreotide

TIPRANKS
·
Sep 19

Cboe data shows mixed options sentiment in Moderna with shares down 1.49%

TIPRANKS
·
Sep 18

LIVE Markets-Cash-Return Stocks Win Back Investor Favor, Leaving Megacaps Behind

Reuters
·
Sep 18

Abeona Therapeutics ‘congratulated’ Ultragenyx on U.S FDA approval of UX111

TIPRANKS
·
Sep 18

Moderna stock rises 8%: can it continue its cancer vaccine success rally?

Bellwether Stocks Movement
·
Sep 18

Moderna Inc. Stock Climbs 8.5%, Outperforms Peers

Dow Jones
·
Sep 18

Ultragenyx confirms FDA approval of Fayuvi

TIPRANKS
·
Sep 18

S&P 500 Top and Bottom Performing Stocks at About 03:30 P.m. EDT

Reuters
·
Sep 18

Moderna Inc Stock (MRNA) Moved Up by 7.25% on Sep 17: Facts Behind the Movement

TradingKey
·
Sep 18

Moderna: Another Day, Another Big Stock Move. is the Cancer Vaccine Rally Back On?

Dow Jones
·
Sep 18

Moderna Shares Hit Four-Week High; Last up 8%

THOMSON REUTERS
·
Sep 17

Nuvation Bio announces FDA approval of sNDA for Ibtrozi

TIPRANKS
·
Sep 17

Bayer receives FDA approval for Kerendia for CKD with type 1 diabetes

TIPRANKS
·
Sep 17

Moderna President Stephen Hoge Disposes of 80,575 Common Shares Worth $11.78 Million

Reuters
·
Sep 17

Cboe data shows mixed options sentiment in Moderna with shares down 2.14%

TIPRANKS
·
Sep 16

ASX biotech expands diagnostics portfolio after FDA approval

Morning Star AU
·
Sep 16

Moderna CFO James M. Mock Disposes of 34,836 Common Shares Worth $4.68 Million

Reuters
·
Sep 15